1
|
Liu Y, Chen C, Xu Z, Scuoppo C, Rillahan CD, Gao J, Spitzer B, Bosbach B, Kastenhuber ER, Baslan T, Ackermann S, Cheng L, Wang Q, Niu T, Schultz N, Levine RL, Mills AA, Lowe SW. Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Nature 2016; 531:471-475. [PMID: 26982726 PMCID: PMC4836395 DOI: 10.1038/nature17157] [Citation(s) in RCA: 187] [Impact Index Per Article: 23.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2015] [Accepted: 01/20/2016] [Indexed: 02/06/2023]
Abstract
Mutations disabling the TP53 tumour suppressor gene represent the most frequent events in human cancer and typically occur through a two-hit mechanism involving a missense mutation in one allele and a 'loss of heterozygosity' deletion encompassing the other. While TP53 missense mutations can also contribute gain-of-function activities that impact tumour progression, it remains unclear whether the deletion event, which frequently includes many genes, impacts tumorigenesis beyond TP53 loss alone. Here we show that somatic heterozygous deletion of mouse chromosome 11B3, a 4-megabase region syntenic to human 17p13.1, produces a greater effect on lymphoma and leukaemia development than Trp53 deletion. Mechanistically, the effect of 11B3 loss on tumorigenesis involves co-deleted genes such as Eif5a and Alox15b (also known as Alox8), the suppression of which cooperates with Trp53 loss to produce more aggressive disease. Our results imply that the selective advantage produced by human chromosome 17p deletion reflects the combined impact of TP53 loss and the reduced dosage of linked tumour suppressor genes.
Collapse
MESH Headings
- Alleles
- Animals
- Cell Transformation, Neoplastic/genetics
- Chromosomes, Human, Pair 17/genetics
- Chromosomes, Mammalian/genetics
- Disease Models, Animal
- Disease Progression
- Female
- Genes, p53/genetics
- Heterozygote
- Humans
- Leukemia, Myeloid, Acute/genetics
- Leukemia, Myeloid, Acute/pathology
- Lymphoma/genetics
- Lymphoma/pathology
- Male
- Mice
- Neoplasms/genetics
- Neoplasms/pathology
- Peptide Initiation Factors/genetics
- Peptide Initiation Factors/metabolism
- RNA-Binding Proteins/genetics
- RNA-Binding Proteins/metabolism
- Sequence Deletion/genetics
- Synteny/genetics
- Tumor Suppressor Protein p53/deficiency
- Eukaryotic Translation Initiation Factor 5A
Collapse
Affiliation(s)
- Yu Liu
- Department of Hematology and Department of Liver Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu 610041, China
- Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Chong Chen
- Department of Hematology and Department of Liver Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu 610041, China
- Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Zhengmin Xu
- Department of Hematology and Department of Liver Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu 610041, China
| | - Claudio Scuoppo
- institute for Cancer Genetics, Columbia University Medical Center, New York, New York 10032, USA
| | - Cory D Rillahan
- Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Jianjiong Gao
- Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Barbara Spitzer
- Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
- Human Oncology & Pathogenesis Program and Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Benedikt Bosbach
- Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Edward R Kastenhuber
- Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Timour Baslan
- Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Sarah Ackermann
- Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Lihua Cheng
- Department of Hematology & Research Laboratory of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Qingguo Wang
- Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Ting Niu
- Department of Hematology & Research Laboratory of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Nikolaus Schultz
- Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Ross L Levine
- Human Oncology & Pathogenesis Program and Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
| | - Alea A Mills
- Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
| | - Scott W Lowe
- Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
- Howard Hughes Medical Institute, New York, New York 10065, USA
| |
Collapse
|
3
|
Chen JP, Wang DL, Yang LL, Wang CY, Wang SS. Ultra-high-performance liquid chromatography tandem mass spectrometry method for the determination of gambogenic acid in dog plasma and its application to a pharmacokinetic study. Biomed Chromatogr 2014; 28:1854-9. [DOI: 10.1002/bmc.3231] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2014] [Revised: 02/21/2014] [Accepted: 04/02/2014] [Indexed: 11/06/2022]
Affiliation(s)
- Jin Pei Chen
- College of Pharmacy, Laboratory of Drug Metabolism and Pharmacokinetics; Anhui University of Chinese Medicine; Hefei Anhui China
| | - Dian Lei Wang
- College of Pharmacy, Laboratory of Drug Metabolism and Pharmacokinetics; Anhui University of Chinese Medicine; Hefei Anhui China
| | - Li Li Yang
- College of Pharmacy, Laboratory of Drug Metabolism and Pharmacokinetics; Anhui University of Chinese Medicine; Hefei Anhui China
| | - Chen Yin Wang
- College of Pharmacy, Laboratory of Drug Metabolism and Pharmacokinetics; Anhui University of Chinese Medicine; Hefei Anhui China
| | - Shan Shan Wang
- College of Pharmacy, Laboratory of Drug Metabolism and Pharmacokinetics; Anhui University of Chinese Medicine; Hefei Anhui China
| |
Collapse
|